All in Health

Sen. Budd, Colleagues Urge DOL to Repeal Biden-Era Rules Harming Farmers, Ease Accessibility for Visas Used by Ag Producers

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.), Senator Tim Scott (R-S.C.), and Rep. Ralph Norman (R-S.C.-5) recently led a bicameral, bipartisan coalition of 84 of their fellow federal lawmakers in sending a letter to Secretary of Labor Lori Chavez-DeRemer urging the Department of Labor to roll back enforcement of Biden-era regulations that have dramatically increased costs for American farmers. Rules increasing the complexity of the H-2A visa program have increased deficits for farmers and created obstacles for producers seeking to enroll in the program.

Sen. Budd, Senate Colleagues Urge Secretary Lutnick to Probe DeepSeek AI’s Connections to Chinese Military, Intelligence Apparatus

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.) recently led a group of Senate colleagues in urging Secretary of Commerce Howard Lutnick to probe allegations made by U.S. officials that DeepSeek Artificial Intelligence has provided support to the People’s Republic of China’s military and intelligence operations. The letter requests that the Department of Commerce investigate these allegations and thoroughly review threats posed by other Chinese open-source models that may be feeding information back to servers with ties to the Chinese government.

Senators Budd, Kelly Introduce SEIZE Act to Authorize Transfer of Confiscated Iranian Weapons to U.S. Partners

 Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Mark Kelly (D-Ariz.) introduced the bipartisan Seized Iranian Arms Transfer Authorization (SEIZE) Act to authorize the use of Presidential Drawdown Authority to transfer confiscated Iranian weapons seized in transit to terror proxies like the Houthi’s in Yemen to U.S. partners for their use. The SEIZE Act would bypass a potentially year-long legal process for the distribution of captured Iranian weapons and equipment held by U.S. CENTCOM, allowing it to be sent directly to U.S. military partners around the globe.  

Senators Budd, Gillibrand, Lummis Introduce Bipartisan Bill to Stop Illegal Use of Digital Assets by Criminals and Terrorists

Washington, D.C.—U.S. Senator Ted Budd (R-N.C.) was joined by Senators Kirsten Gillibrand (D-N.Y.) and Cynthia Lummis (R-Wyo.) in reintroducing the Financial Technology Protection Act. The bipartisan bill aims to address the illegal use of financial technologies and digital assets to prevent sanctions evasion, terrorist financing, and money laundering. 

Sens. Budd, Heinrich Introduce Amendment to Crack Down on Illicit Anti-Obesity Drugs Entering the U.S. from China

 Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Martin Heinrich (D-N.M.) recently introduced an amendment to the 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act to ensure the Food and Drug Administration (FDA) can activate regulatory and enforcement authorities to prevent the importation of illicit weight loss drugs and Active Pharmaceutical Ingredients (API) from the Republic of China and other foreign countries.

Op-Ed: Expand Access to Anti-Obesity Medications to Improve Lives, Reduce Long Term Costs

Obesity rates are skyrocketing in our nation. In the last two decades, obesity has doubled among American adults.  Despite the growing consensus and greater understanding of the disease, many people continue to view obesity as a lifestyle choice or personal failure. It’s important to understand that for many Americans, obesity is not a choice.  It’s a chronic disease that affects every layer of a patient’s life.

Senator Michael Lazzara: Rescheduling cannabis from a Schedule I to a Schedule III drug

I have countless Veterans in my district and am a Veteran myself and have long championed policies that promote economic growth, public safety, and personal freedom. That’s why I side with President Trump on rescheduling cannabis from a Schedule I to a Schedule III drug—a move that would not only facilitate research opportunities in the industry but also establish better regulatory frameworks for businesses and consumers alike.